Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

AI can now understand health signals from 15 seconds of your voice, including type 2 diabetes, fatigue and stress

Speechmatics and thymia have announced a groundbreaking collaboration to integrate medical-grade speech-to-text technology with clinical-grade voice biomarker intelligence, enabling the identification of over 30 health signals from just 15 seconds of natural speech. This innovative platform processes audio to detect indicators such as stress, fatigue, depression, anxiety, type 2 diabetes, and driver impairment, delivering actionable insights in real time with an accuracy exceeding 85%. Notably, this solution requires no additional hardware, making it accessible for widespread deployment.

The significance of this development lies in its potential to transform health monitoring and intervention strategies. Built on a robust dataset of over 75,000 unique voices and validated through more than 20 peer-reviewed publications, thymia’s technology leverages both acoustic and linguistic patterns to extract health signals. The integration of Speechmatics’ advanced speech engine ensures that the platform performs effectively across diverse accents and non-native speakers, addressing a critical barrier in the scalability of voice-based health assessments. As the EU mandates driver fatigue monitoring in new vehicles by July 2026, this technology positions itself at the forefront of a rapidly growing $5 billion market for voice biomarker applications.

The takeaway from this partnership is its potential to shift current paradigms in healthspan research and clinical practice. By enabling real-time health assessments through everyday voice interactions, this technology could streamline patient monitoring and intervention, significantly reducing the burden on healthcare systems. Furthermore, it opens avenues for drug development timelines by providing immediate feedback on patient states, thus facilitating more responsive and personalized treatment strategies. As this technology matures and gains regulatory approval, it may redefine how we approach health monitoring and preventative care in both clinical and everyday settings.

Source: globenewswire.com